Compare Packaging Corporation of America (PKG) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs Repligen Corporation Common Stock — how do they compare? Packaging Corporation of America trades at $230.05 (market cap $20.49B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Packaging Corporation of America is the larger of the two by market cap, and Packaging Corporation of America pays a 2.61% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 47 Days and Repligen Corporation Common Stock for 0 Days on average.
| PKG | RGEN | |
|---|---|---|
Market Cap | $20.49B | $11.14B |
Volume | 566,331 | 1,259,263 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $194.57 |
52-Week Low | $191.68 | $102.87 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | $24.30B | $11.02B |
Dividend Yield | 2.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $231.65, up 1.68% on the day, with a bearish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q1 and Q2 2026 but missing in Q4 2025, while revenue is projected to grow to $9.5B in 2026. Analyst consensus is a 'Hold' with a $272.43 price target, and the stock offers a $1.50 quarterly dividend. Recent news highlights institutional investments and upcoming Q3 earnings discussion.
PKG presents a cautious outlook with steady revenue growth offset by margin pressures, as net income is expected to decline to $692M in 2026. The primary opportunity lies in the consensus price target suggesting ~18% upside, but risks include rising costs, competitive pressures, and bearish technical trends. Investors should weigh the dividend yield against earnings volatility and valuation multiples above sector averages.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
